FY2025 Earnings Forecast for CVE:HIV Issued By Roth Capital

HIVE Blockchain Technologies Ltd. (CVE:HIVFree Report) – Stock analysts at Roth Capital upped their FY2025 earnings per share estimates for shares of HIVE Blockchain Technologies in a report issued on Wednesday, January 8th. Roth Capital analyst D. Aftahi now expects that the company will earn ($0.53) per share for the year, up from their previous forecast of ($0.54). Roth Capital currently has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.10) EPS, Q1 2026 earnings at ($0.09) EPS, Q3 2026 earnings at ($0.09) EPS, FY2026 earnings at ($0.16) EPS and FY2028 earnings at ($0.09) EPS.

A number of other research analysts also recently weighed in on the stock. Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Keefe, Bruyette & Woods upgraded HIVE Blockchain Technologies to a “moderate buy” rating in a research report on Wednesday, January 8th. Finally, Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Thursday, September 19th. Four equities research analysts have rated the stock with a strong buy rating, According to MarketBeat, the company has an average rating of “Strong Buy”.

Check Out Our Latest Analysis on HIV

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.

Further Reading

Earnings History and Estimates for HIVE Blockchain Technologies (CVE:HIV)

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.